CircRNA ATF6 suppresses bladder cancer cell proliferation and migration via miR-146a-5p/FLNA axis

Bing Lu1, Yongqiang Zhou2, Zheng Ma2

  • 1Department of Urology, Dushu Lake Hospital Affiliated to Soochow University, Suzhou, Jiangsu 215000, China.

Mutation Research
|August 25, 2024
PubMed
Abstract

Insights

Circular RNA ATF6 (circRNA ATF6) suppresses bladder cancer (BCa) progression by inhibiting cell growth, migration, and invasion. This mechanism involves the microRNA-146a-5p (miR-146a-5p) and filamin A (FLNA) pathway, offering potential therapeutic targets for BCa.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Bladder cancer (BCa) presents a significant global health challenge with increasing incidence and mortality.
  • Circular RNA ATF6 (circRNA ATF6) is downregulated in BCa, and its functional role remains largely unelucidated.
  • Understanding the molecular mechanisms underlying BCa progression is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To investigate the function and molecular mechanism of circRNA ATF6 in bladder cancer.
  • To explore the potential interaction between circRNA ATF6, microRNA-146a-5p (miR-146a-5p), and filamin A (FLNA) in BCa.
  • To evaluate the therapeutic potential of circRNA ATF6 in preclinical models of BCa.

Main Methods:

  • Differential expression analysis of circRNA ATF6, miR-146a-5p, and FLNA using GEO2R and RT-qPCR.
  • Assessment of circRNA ATF6 stability and cellular localization via actinomycin D, RNase R, and FISH assays.
  • Functional assays including CCK-8, colony formation, wound-healing, and Transwell assays to evaluate BCa cell behavior.
  • Luciferase reporter assays, RNA pull-down, and RIP experiments to confirm molecular interactions.
  • In vivo studies using tumor-bearing mice to assess the effect of circRNA ATF6 on tumor growth.

Main Results:

  • CircRNA ATF6 and FLNA were downregulated, while miR-146a-5p was upregulated in BCa tissues.
  • CircRNA ATF6 demonstrated stability and cytoplasmic localization, suppressing BCa cell viability, colony formation, and invasion.
  • CircRNA ATF6 directly sponged miR-146a-5p, and miR-146a-5p targeted FLNA, inhibiting BCa progression.
  • Overexpression of circRNA ATF6 significantly reduced tumor growth and weight in vivo.

Conclusions:

  • CircRNA ATF6 acts as a tumor suppressor in bladder cancer by inhibiting cell proliferation, migration, and invasion.
  • The circRNA ATF6/miR-146a-5p/FLNA axis represents a novel regulatory pathway in BCa pathogenesis.
  • CircRNA ATF6 holds potential as a therapeutic target for bladder cancer treatment.